Edgar Filing: Morgan W. David

Ownership Submission

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0104

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

Â Morgan W. David

2. Date of Event Requiring Statement (Month/Day/Year)
05/12/2012

3. Issuer Name and Ticker or Trading Symbol
ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. [MDRX]

(Last)

(First)

(Middle)

222 MERCHANDISE MART, STE. 2024

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	_____ 10% Owner
__X__ Officer (give title below)	_____ Other (specify below)
Interim Chief Financial Ofcr.

5. If Amendment, Date Original Filed(Month/Day/Year)

(Street)

CHICAGO,Â ILÂ 60654

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	24,800 ⁽¹⁾	D	Â

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option	Â ⁽²⁾	08/14/2015	Common Stock	12,000 ⁽²⁾	$ 19.25	D	Â
Stock Option	Â ⁽³⁾	11/14/2015	Common Stock	4,218 ⁽³⁾	$ 11.5	D	Â
Stock Option	Â ⁽⁴⁾	08/14/2016	Common Stock	20,999 ⁽⁴⁾	$ 14.2	D	Â
Stock Option	Â ⁽⁴⁾	08/14/2015	Common Stock	12,000 ⁽⁵⁾	$ 19.25	D	Â
Stock Option	08/14/2010	11/14/2015	Common Stock	3,282 ⁽⁶⁾	$ 11.5	D	Â
Stock Option	08/14/2010	08/16/2016	Common Stock	7,001 ⁽⁷⁾	$ 14.2	D	Â

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Morgan W. David 222 MERCHANDISE MART, STE. 2024 CHICAGO,Â ILÂ 60654	Â	Â	Â Interim Chief Financial Ofcr.	Â

Signatures

Kathie Kittner by power of attorney for W. David Morgan		05/24/2012
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Of the 24,800 shares beneficially owned, 9,239 are vested equity awards and therefore represent shares held outright. An additional 3,792 equity awards will vest in 2012; 4,701 equity awards will vest in 2013; 3,534 equity awards will vest in 2014; and 3,534 equity awards will vest in 2015.
(2)	Received pursuant to the Agreement and Plan of Merger, dated as of June 9, 2010, among Allscripts-Misys Healthcare Solutions, Inc. (which has changed its name to Allscripts Healthcare Solutions, Inc.)("Allscripts"), Arsenal Merger Corp. and Eclipsys Corporation (the "Merger Agreement")in exchange for a stock option to acquire 10,000 shares of Eclipsys Corporation common stock for $23.10 per share. Vests as to 500 shares monthly for twenty-four (24) months beginning on September 14, 2010.
(3)	Received pursuant to the Merger Agreement in exchange for a stock option to acquire 3,515 shares of Eclipsys Corporation common stock for $13.79 per share. Vests as to 156 shares monthly for twenty-seven (27) months beginning on September 14, 2010.
(4)	Received pursuant to the Merger Agreement in exchange for a stock option to acquire 17,499 shares of Eclipsys Corporation common stock for $17.03 per share. Vests as to 583 shares monthly for thirty-six (36) months beginning on September 14, 2010.
(5)	Received pursuant to the Merger Agreement in exchange for a stock option to acquire 10,000 shares of Eclipsys Corporation common stock for $23.10 per share. Options are fully vested as of August 14, 2010.
(6)	Received pursuant to the Merger Agreement in exchange for a stock option to acquire 2,735 shares of Eclipsys Corporation common stock for $13.79 per share. Options are fully vested as of August 14, 2010.
(7)	Received pursuant to the Merger Agreement in exchange for a stock option to acquire 5,834 shares of Eclipsys Corporation common stock for $17.03 per share. Options are fully vested as of August 14, 2010.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.